Xbrane Expands Capacity To Target More Biosimilars

Eyeing Further Blockbuster Biologics After Move To Solna Premises

 
• By Dave Wallace

Sweden’s Xbrane Biopharma is moving to new premises that will expand its development capacity and allow it to target several blockbuster biologics with patents expiring over the next decade.

Stockholm_Aerial
Xbrane is moving its headquarters to its new Solna campus • Source: Shutterstock

More from Strategy

More from Business